Prime Medicine, Inc.

General ticker "PRME" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $395.8M (TTM average)

Prime Medicine, Inc. follows the US Stock Market performance with the rate: 54.3%.

Estimated limits based on current volatility of 4.4%: low 4.02$, high 4.39$

Factors to consider:

  • Total employees count: 175 as of 2022
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.04$, 5.84$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.19$, 5.98$]

Financial Metrics affecting the PRME estimates:

  • Positive: with PPE of -1.7 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -36.65 <= 0.33
  • Positive: 41.86 < Shareholder equity ratio, % of 51.48 <= 63.39
  • Positive: Investing cash flow per share per price, % of 20.42 > -0.66
  • Positive: Inventory ratio change, % of -70.39 <= -0.75
  • Positive: Interest expense per share per price, % of 0 <= 0.01

Similar symbols

Short-term PRME quotes

Long-term PRME plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.00MM $2.98MM
Operating Expenses $204.79MM $205.45MM
Operating Income $-204.79MM $-202.47MM
Non-Operating Income $6.38MM $6.58MM
R&D Expense $147.91MM $155.29MM
Income(Loss) $-198.41MM $-195.88MM
Taxes $-0.28MM $0.00MM
Profit(Loss)* $-198.13MM $-195.88MM
Stockholders Equity $133.07MM $153.15MM
Assets $193.85MM $297.51MM
Operating Cash Flow $-165.41MM $-122.86MM
Capital expenditure $8.72MM $7.29MM
Investing Cash Flow $18.71MM $68.46MM
Financing Cash Flow $0.66MM $195.88MM
Earnings Per Share** $-2.18 $-1.65

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.